PriceTargets.com logo

SNDL - SNDL Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $4.00
  • Forecasted Upside: 100.00%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$2.00 As of 04/24/2024 01:00 AM ET
▼ -0.07 (-3.38%)

This chart shows the closing price for SNDL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New SNDL Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SNDL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SNDL

Analyst Price Target is $4.00
▲ +100.00% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for SNDL in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 100.00% upside from the last price of $2.00.

This chart shows the closing price for SNDL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 2 polled investment analysts is to buy stock in SNDL. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/1/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/30/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/30/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/29/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/22/2023ATB CapitalLower TargetOutperform$6.00 ➝ $4.00Low
11/21/2023Atb Cap MarketsReiterated RatingOutperformLow
11/28/2022Cantor FitzgeraldBoost TargetNeutral$3.56 ➝ $3.60Low
8/16/2022Cantor FitzgeraldBoost TargetNeutral$3.56Low
8/16/2022Canaccord Genuity GroupUpgradeHold ➝ Speculative Buy$5.00Low
8/16/2022RoweUpgradeHold ➝ BuyLow
5/17/2022Atb Cap MarketsUpgradeSector Perform ➝ OutperformHigh
5/3/2022BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$6.00 ➝ $7.00Low
7/21/2021ATB CapitalUpgradeUnderperform ➝ Sector PerformHigh
7/20/2021Atb Cap MarketsUpgradeUnderperform ➝ Sector PerformHigh
3/16/2021BMO Capital MarketsReiterated RatingMarket Perform ➝ Underperform$4.00High
3/10/2021Cantor FitzgeraldInitiated CoverageNeutral$11.50High
3/10/2021BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$4.00High
11/12/2020Atb Cap MarketsDowngradeSector Perform ➝ UnderperformHigh
8/17/2020CIBCUpgradeSector Underperform ➝ NeutralHigh
6/29/2020BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$10.00High
4/2/2020BMO Capital MarketsDowngradeMarket Perform ➝ UnderperformHigh
2/24/2020CowenDowngradeOutperform ➝ Market Perform$100.00 ➝ $15.00Medium
1/30/2020CIBCDowngradeNeutral ➝ UnderperformerHigh
10/31/2019BMO Capital MarketsDowngradeOutperform ➝ Market Perform$80.00 ➝ $40.00Medium
9/27/2019BarclaysInitiated CoverageOverweight$70.00High
9/10/2019BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$120.00High
8/26/2019CowenInitiated CoverageOutperform$200.00High
8/26/2019BMO Capital MarketsInitiated CoverageMarket Perform$120.00 ➝ $120.00High
8/26/2019CIBCInitiated CoverageNeutral$110.00 ➝ $110.00High
(Data available from 4/24/2019 forward)

News Sentiment Rating

0.53 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2023
  • 2 very positive mentions
  • 5 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2023
  • 4 very positive mentions
  • 10 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2023
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2024
  • 2 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2024
  • 2 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
3/25/2024
  • 12 very positive mentions
  • 7 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2024

Current Sentiment

  • 12 very positive mentions
  • 7 positive mentions
  • 3 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

SNDL logo
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores. In addition, the company produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
Read More

Today's Range

Now: $2.00
Low: $1.97
High: $2.07

50 Day Range

MA: $1.68
Low: $1.31
High: $2.50

52 Week Range

Now: $2.00
Low: $1.25
High: $2.67

Volume

6,158,440 shs

Average Volume

5,109,314 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.42

Frequently Asked Questions

What sell-side analysts currently cover shares of SNDL?

The following Wall Street analysts have issued reports on SNDL in the last twelve months: Atb Cap Markets, and ATB Capital.
View the latest analyst ratings for SNDL.

What is the current price target for SNDL?

1 Wall Street analysts have set twelve-month price targets for SNDL in the last year. Their average twelve-month price target is $4.00, suggesting a possible upside of 100.0%. ATB Capital has the highest price target set, predicting SNDL will reach $4.00 in the next twelve months. ATB Capital has the lowest price target set, forecasting a price of $4.00 for SNDL in the next year.
View the latest price targets for SNDL.

What is the current consensus analyst rating for SNDL?

SNDL currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SNDL will outperform the market and that investors should add to their positions of SNDL.
View the latest ratings for SNDL.

What other companies compete with SNDL?

Other companies that are similar to SNDL include 180 Life Sciences, 60 Degrees Pharmaceuticals, Aclarion, Ainos and Alpha Tau Medical. Learn More about companies similar to SNDL.

How do I contact SNDL's investor relations team?

SNDL's physical mailing address is 919 11 AVENUE SW SUITE 200, CALGARY A0, T2R1P3. The company's listed phone number is (844) 249-6746 and its investor relations email address is [email protected]. The official website for SNDL is www.sundialcannabis.com. Learn More about contacing SNDL investor relations.